Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MLN0002

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
We read with interest the study by Colombel et al 1 on vedolizumab (VDZ) safety in Crohn's disease (CD) and ulcerative colitis… Expand
Review
2015
Review
2015
Crohn’s disease and ulcerative colitis are two chronic inflammatory bowel conditions. Current approved biologic therapies are… Expand
  • table 1
Review
2015
Review
2015
As part of its single technology appraisal (STA) process, the National Institute for Health and Care Excellence (NICE) invited… Expand
  • table 1
  • table 2
  • table 3
Highly Cited
2012
Highly Cited
2012
Background: Biological therapies that antagonize specific molecules have demonstrated efficacy in inflammatory bowel diseases… Expand
  • table 1
  • table 1
  • figure 1
  • table 2
  • table 3
Review
2011
Review
2011
Crohn’s disease and ulcerative colitis are two chronic inflammatory bowel diseases. Current biologic therapies are limited to… Expand
  • table 1
  • table 2
  • figure 2
2010
2010
  • D. Baumgart
  • Inflammatory bowel diseases
  • 2010
  • Corpus ID: 35402548
 
Highly Cited
2008
Highly Cited
2008
BACKGROUND & AIMS Selective blockade of lymphocyte-vascular endothelium interactions in the gastrointestinal tract is a promising… Expand
  • figure 1